
arvind krishnamurthy
226 posts

arvind krishnamurthy
@arvindkmurthy
surgical oncologist, @Cancer Institute (WIA) Adyar, Tweets personal





With Ashok and Arvind. Students not so long back and now both leading national conferences last weekend and this. Time flies but for me there can be nothing more satisfying than passing the baton to youngsters like them. Great show guys!!!!

Visited the prestigious Adyar Cancer centre,Chennai as a proctor for the Robotic Gyn oncology program..Best wishes to Dr Ujwala n her team..Happy to meet Dr Arvind Krishnamurthy @arvindkmurthy .Good to catch up in person with Twitter friend @anandoncologist and Jayashree..



DrKanuj pesenting our work at annual meetng of @SocSurgOnc. Accepted for being awarded best paper in the annual meeting of Indian Association of Surgical Oncology. Our unit gets this 3rd time in the last 5 years. @Docvk2 also from our dept presents here. @arvindkmurthy @CI_WIA

Excellent learning in 4th annual review head & neck cancers. Today: nasopharynx, salivary gland & thyroid tumors. A very important point made regarding analplastic thyroid cancers...Do not loose hope! @oncoalert @DrVijayPatil11 @Nandinimenon18 @SewantiLimaye @arvindkmurthy #HNSCM


A group led by @drsabita & @docpriyar set out to look at the impact of COVID_19 on physicians in India from a gender perspective, our hypothesis being that a greater burden of familial/domestic responsibilities fell on women. Full paper: ascopubs.org/doi/pdf/10.120… 1/n






World No Tobacco Day: Quit smoking, stay safe from COVID-19 Quitting smoking has many benefits. Now, there is one very compelling reason to quit. Smokers, when compared to non-smokers, stand a higher risk of developing severe COVID-19 : doctors @THChennai thehindu.com/news/national/…

Good approach to combine screening for COVID and TB in vulnerable communities. Both chest X-ray & molecular testing if widely available, can help in control of many infectious diseases @paimadhu @FINDdx @ICMRDELHI @MoHFW_INDIA @


A new cross-sectional study demonstrates that the vast majority (90%) of pts w cancer with solid tumors on active anti-cancer therapy respond adequately to #SARSCoV2 mRNA vaccination, suggesting that vaccinating cancer patients should be high priority ja.ma/34obFQZ


